交联聚合物皮肤屏障膜治疗中重度特应性皮炎的成人初步研究
一项单中心、开放标签试点研究纳入10例中重度特应性皮炎成人,在选定治疗区域每日最多两次外用交联聚合物层(XPL)共30天。第30天时9例中8例 investigator's global assessment 从基线中重度改善至清除或几乎清除,所有受试者瘙痒从基线轻度至重度改善为轻微或无瘙痒,出现1例轻度渗出性皮炎不良事件。结论认为XPL可能作为特应性皮炎治疗的有效辅助手段,需更大样本对照研究验证。
要点
- XPL在中重度AD成人中显示改善IGA和瘙痒的潜力
- 30天时8/9例患者IGA达清除或几乎清除
- 仅1例轻度渗出性皮炎不良事件,耐受性尚可
核心结论
- XPL可能作为特应性皮炎治疗的有效辅助手段,但需更大样本对照研究证实。
研究设计与样本
- 单中心、开放标签试点研究,纳入10例中重度特应性皮炎成人,选定治疗区域每日最多两次外用XPL共30天。
主要发现
- 第30天时9例中8例 investigator's global assessment 从基线中重度改善至清除或几乎清除。
- 瘙痒从基线轻度至重度改善为第30天所有受试者轻微或无瘙痒。
- 出现1例轻度渗出性皮炎不良事件。
临床怎么用
- XPL可作为中重度特应性皮炎辅助治疗的可选方案,但需结合患者情况个体化使用。
局限性
- 样本量小、开放标签设计、缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Occlusive treatments are a mainstay in atopic dermatitis (AD) management but may not be well tolerated or lack compliance. A comfortable, semiocclusive, artificial skin barrier that is well tolerated, provides protection, and reduces water loss is needed. OBJECTIVE: To evaluate the potential tolerability and therapeutic benefits of a crosslinked polymer layer (XPL) in adults with AD. METHODS: A single-center, open-label pilot study was conducted involving 10 subjects with moderate to severe AD. Subjects applied XPL up to twice daily for 30 days on a selected treatment area. Investigator's Global Assessment, clinical signs of eczema, and pruritus were assessed on days 1, 3, 5, 15, and 30. Film durability and patient satisfaction were also evaluated. RESULTS: Investigator's Global Assessment scores improved from moderate to severe at baseline to clear to almost clear in 8 of 9 patients at day 30. Pruritus improved from trace to severe itching (baseline) to all subjects having trace to no itching at day 30. There was 1 adverse event of mild exudative dermatitis. LIMITATIONS: The study was limited by small sample size, open-label design, and lack of control. CONCLUSION: XPL may be an effective adjuvant in AD treatment. A larger study with a control group is warranted.
引用
- Bouthillette M, Beccati D, Akthakul A, et al. A crosslinked polymer skin barrier film for moderate to severe atopic dermatitis: A pilot study in adults. J Am Acad Dermatol. 2019. PMID: 31589946. doi:10.1016/j.jaad.2019.09.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。